Fanconi anemia (FA) patients have an increased risk of acute GVHD (aGVHD) after hematopoietic SCT, with hypersensitivity to DNAcross-linking agents and defective DNA repair. MicroRNA-34 and p53 can induce apoptosis after DNA damage.Here we assessed epithelial cell apoptosis, and studied TP53 and miR-34a expression in the skin and gut biopsies in five non-transplanted FA patients, in 20 FA patients with aGVHD and in 25 acquired aplastic anemia patients (AA). Epithelial apoptosis was higher in FA than in acquired AA patients in both the skin and gut biopsies, though they had a similar preparative regimen. Further study on gut biopsies in FA patients showed that this deleterious effect was not linked to TP53 gene overexpression. As, among p53-independent signaling pathways of apoptosis, the microRNA-34 family mimics p53 apoptotic effects in response to DNA damage, we studied miR-34a expression in the same series of FA patients' gut biopsies. MiR-34a expression level was higher in severe aGVHD compared with non-aGVHD subjects or non-transplanted patients, and significantly related to apoptotic cell numbers across the three groups of FA patients. Thus, in FA patients, increased apoptosis occurs in target epithelial cells of severe aGVHD, and this deleterious effect is linked to overexpression of miR-34a but not TP53.
INTRODUCTION
Fanconi anemia (FA) is a rare inherited disorder characterized by developmental defects, genomic instability and progressive BM failure. 1 Hematopoietic allogeneic SCT (HSCT) can restore normal hematopoiesis, [2] [3] [4] but these patients have an increased risk of grades 2-4 acute GVHD (aGVHD). 5 At the cellular level, the hallmarks of FA are hypersensitivity to DNA-cross-linking agents and defective DNA repair. 6 Unrepaired DNA damage can further activate p53-dependent 7 and p53-independent 8 signaling pathways of apoptosis. MicroRNAs, a class of small non-coding RNAs mediating posttranscriptional silencing of mRNAs, participate in the control of cell fate. 9 Among them, the microRNA-34 family mimics p53 biological effects by inducing cell cycle arrest and apoptosis in response to DNA damage. 10, 11 Here we studied epithelial cell apoptosis, TP53 and miR-34a expression in skin and gut biopsies in non-transplanted FA patients, and FA patients with aGVHD of different grades. To take the role of the conditioning regimen into account, we compared the results obtained in 25 FA patients with those obtained for 25 acquired aplastic anemia patients (AA), who had received transplants at Saint Louis Hospital from HLA-genotypic identical siblings, with a similar conditioning regimen.
MATERIALS AND METHODS Patients
Twenty-five patients with FA (15 males, 10 females) were included in the study. Among them, 11 carried the FANCA mutations and 4 the FANCC mutations. Five of them had not received any transplant at the time of the study; the 20 others had undergone HSCT from HLA-genotypic-identical sibling donors in a single center (Hô pital Saint-Louis, Paris, France) between 1999 and 2009. Their preparatory regimen was dose-adapted CY (40 mg/kg) with or without thoracic-abdominal irradiation. 5 Twenty-five age-and sex-matched patients with acquired AA were also included in the study. They received HSCT in the same center in the same period, with a preparatory regimen including CY (200 mg/kg) with or without thoracicabdominal irradiation 12 
Biopsies
Skin and gut biopsies were performed for diagnostic purposes. Patients were informed that part of the material remaining after the diagnosis had been established could be used for research and gave their informed consent to the study. The Hô pital Saint Louis ethical review board approved the protocol.
The skin biopsy specimens, performed in case of rash, were cut into three parts and were (i) formalin-fixed and paraffin-embedded, (ii) glutaraldehyde-fixed and resin-embedded, (iii) snap-frozen. Duodenal biopsies were performed in the case of digestive symptoms requiring an upper digestive endoscopy for GVHD diagnosis. Six biopsies were obtained and two were formalin-fixed, two glutaraldehyde-fixed and two snap-frozen.
GVHD histological grading was performed by two different pathologists (MR, AJ), according to the consensus criteria 13 microscope with a 0.344-mm 2 field size at Â 400 magnification (Olympus, Tokyo, Japan). Counts of double-positive cytokeratin/cleaved-caspase3 cells were performed on epidermal and duodenal epithelial samples on five different fields by two independent observers, and the results were expressed as means ± s.d.
Molecular analyses
Quantification of miR-34a expression. For all biopsies, total RNA was extracted from four 20-mm-thick paraffin sections using RecoverAll total nucleic-acid isolation kit (Ambion, Cambridgeshire, UK) following the manufacturer's protocol. MiR-34a expression was analyzed by RQ-PCR using miRNA-reverse-transcription-kit, hsa-miR-34a assay and 7500HT Fast RT-PCR system (all from Applied Biosystems, Darmstadt, Germany).
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RNU24 was used as an endogenous control, and normal duodenum from surgical pieces for calibration. A relative quantification was done using the 2 À DDCT method. Quantification of TP53 expression. For all biopsies, total RNA was extracted from ten 15-mm-thick frozen sections using Rneasy-mini-kit (Qiagen, Courtaboeuf, France) and converted to cDNA using the High-capacity cDNA archive-kit (Applied Biosystems). TP53 expression (Hs01034253_m1, Applied Biosystems) was analyzed on 7500HT Fast Real-Time-PCR system, with human transcription factor IID/TATA-binding protein (TBP, Hs99999910_m1, Applied Biosystems) as the internal control and normal duodenum frozen sections as the calibrator. A relative quantification was done using the 2 À DDCT method. 17 
Statistical analyses
Student's t-test was used to compare apoptotic cell numbers in the skin and gut biopsies from non-transplanted FA patients, and from FA patients with aGVHD grades 0-1 and 2-4. It was also used to compare TP53 and miR-34a expression levels in the same three groups of FA patients, and to compare apoptotic cell numbers in acquired AA patients with aGVHD grades 0-1 and 2-4. Differences were considered significant when the two-sided P-value was o0.05. Correlations between apoptotic epithelial cell numbers and TP 53 or miR-34a expression levels were assessed using Z-test. All statistical analyses were performed using SAS 8.2 software (SAS Institute Inc, Cary, NC, USA).
RESULTS
Increased epithelial apoptosis in FA patients with severe aGVHD Using TUNEL (terminal deoxynucleotidyl transferasedUTP nick end labeling), we identified a large number of apoptotic cells in the skin and gut of FA patients with severe acute GVHD ( Figure 1 ). When on the same tissue samples we performed a double immuno-fluorescent staining using Abs directed against cytokeratin and caspase 3, we found that almost all apoptotic cells were epithelial cells. Apoptotic epithelial cells were then counted in biopsies from non-transplanted FA patients (skin 1±0.4; gut 1±0.7), and from FA patients with aGVHD grades 0-1 (skin1 ± 0.9; gut 1.4 ± 1.3) and grades 2-4 (skin 6.2 ± 2.9; gut 8 ± 2.4) (Figure 2 ). Apoptotic epithelial cells in both the skin and gut were significantly more numerous in FA patients with aGVHD grades 2-4 than in FA patients with grades 0-1 (Po0.01 skin, Po0.01 gut), and more numerous than in non-transplanted FA patients (Po0.01 skin, Po0.01 gut). In addition, there was no significant relationship between the number of apoptotic epithelial cells and the FANCA or FANCC mutations.
When we compared the results obtained from FA patients with those obtained from acquired AA patients having received HSCT, in the same center with a similar conditioning regimen except for dose-adapted CY, there was a significant difference in apoptotic epithelial cell numbers only in patients with aGVHD grades 2-4 ( Figure 2 and Supplementary Figure 1) . Apoptotic cells were more numerous in FA patients than in acquired AA patients, both in the skin (6.2 ± 2.9 versus 2.4 ± 0.9, Po0.05) and in the gut (8 ± 2.4 versus 4±2, Po0.05). No significant difference in either the skin or gut biopsies was found for apoptotic epithelial cell numbers in FA and acquired AA patients with grades 0-1 GVHD (Figure 2 and Supplementary Figure 1) .
Increased epithelial apoptosis is related to miR-34a overexpression When the level of miR-34a expression was assessed in the gut biopsies of FA patients, we found a significantly higher level of expression when the results in the gut biopsies of FA patients with aGVHD grades 2-4 (27 ± 4) were compared with the results obtained in the gut biopsies of FA patients with aGVHD grades 0-1 (6.8±0.5, Po0.01).
There was also a significant higher level of miR-34a expression when the results in the gut biopsies of FA patients with aGVHD grades 2-4 (27 ± 4) were compared with the results obtained in the gut biopsies of non-transplanted FA patients (1.4±0.3, Po0.01) (Figure 3a ).
In addition, when the gut biopsies from all FA patients were analyzed together, the levels of miR-34a expression were significantly related to the numbers of apoptotic cells (R 2 ¼ 0.7418, Po0.05) (Figure 3b ). When the levels of TP53 gene expression were assessed in the same gut samples, we did not find any significant change across the three groups of FA patients. Further statistical analyses showed that when the gut biopsies from all FA patients were analyzed together, there was no correlation between the levels of TP53 expression and the numbers of apoptotic epithelial cells (R 2 ¼ 0.0559, P ¼ 0.62) (Figure 3c ). In addition, the levels of TP53 expression were not related to the levels of miR-34a expression when the gut biopsies from all FA patients were analyzed together (R 2 ¼ 0.0118, P ¼ 0.62) (Figure 3d ).
DISCUSSION
We have shown here that in FA patients, increased apoptosis occurs in the target epithelial cells of severe aGVHD and that this deleterious effect is linked to overexpression of miR-34a but not TP53.
FA is an inherited disorder characterized by developmental defects, genomic instability and progressive BM failure. 1 At the cellular level, FA patients have defective DNA repair, 6 and therefore in these patients we first assessed the number of apoptotic epithelial cells in the skin and gut biopsies performed before HSCT for diagnostic purposes. The fact that, in both the skin and gut biopsies, apoptotic cell numbers were small in nontransplanted FA patients implies that the high level of epithelial apoptosis observed in FA patients with aGVHD was not due to damage that existed before HSCT.
As FA patients also have DNA hypersensitivity to DNA-crosslinking agents, 6 we then set out to assess the role of the conditioning regimen on the epithelial cell apoptosis in these patients. The conditioning regimen, particularly radiotherapy, could have a role in the epithelial cell apoptosis, as TP53-induced apoptosis is involved in radiation toxicity in normal tissues. 18 Therefore, we compared the results obtained from FA patients with those obtained from acquired AA patients having received HSCT in the same center with a similar conditioning regimen except for dose-adapted CY. In these two series of patients, we found a significant difference in apoptotic epithelial cell numbers only in patients with aGVHD grades 2-4, but not in those with grades 0-1. Thus, the conditioning regimen did not appear to be a major cause of epithelial cell apoptosis in the FA patients.
In these FA patients, apoptotic epithelial cell numbers were related to the severity of aGVHD in both the skin and gut, two target organs of the alloimmune reaction. A direct relationship between this alloimmune reaction and epithelial cell apoptosis can be discussed, as cytotoxic T-lymphocytes are able to induce caspase-dependent apoptosis in their target cells through a death receptor-dependent pathway. 19 The fact that severe aGVHD induced larger numbers of apoptotic epithelial cells in the skin and gut of FA patients compared with acquired AA patients could be linked to a greater sensitivity of FA epithelial cells to the alloimmune reaction. Studies in Fanc À / À mice 20 and in FA children 21 have shown the sensitivity of hematopoietic progenitor cells to IFN-g and TNF-a, two cytokines involved in aGVHD 22 and able to induce apoptosis by priming the Fas pathway. 21 Apoptosis through Fas engagement has also been observed in the skin and gut epithelial cells in an experimental model of acute alloimmune reaction. 23 We further studied whether the increased epithelial apoptosis that we found in the two target organs of aGVHD in FA patients was related to TP53 overexpression, as unrepaired DNA damage can activate p53-dependent signaling pathways of apoptosis. 7 However, TP53 gene expression levels showed no significant change across the three groups of the gut biopsies in FA patients: the gut biopsies performed before HSCT with aGVHD grades 0-1 and grades 2-4. Nor were they related to apoptotic epithelial cell numbers.
As among p53-independent signaling pathways of apoptosis the microRNA-34 family mimics p53 biological effects by inducing cell cycle arrest and apoptosis in response to DNA damage, 10, 11 we studied miR-34a expression in the same series of FA patients' gut biopsies. We found a significantly higher level of miR-34a expression in aGVHD grades 2-4 compared with grade 0-1 or with non-transplanted FA patients. In addition, this miR-34a expression was significantly related to apoptotic cell numbers across the three groups of FA patients. To date, there has been no report for miR-34a expression on normal epithelial cells, including normal gut epithelial cells. Experimental studies on neuroblastoma cells demonstrated that miR-34a is able to induce a caspase-dependent apoptotic pathway. 24 In colon cancer, activation of miR-34a contributes to p53-mediated apoptosis, 25 but inactivation of the TP53 gene by homologous recombination in colon cancer cell lines also results in miR-34a-induced cell death. 11 As in the gut biopsies of FA patients with severe aGVHD TP53 gene expression levels remained unchanged while miR-34a expression significantly increased, a direct effect of miR-34a of this type on gut epithelial cell apoptosis could be involved. This miR-34a damage-related effect could be particularly deleterious in FA patients because of the constitutive activation of caspase3, a key enzyme for apoptosis, identified in FA cells. 26 
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